As precision medicine advances, researchers continue to discover new ways to use monoclonal antibodies (mAb) and polyclonal antibodies (pAb) to treat immunologic conditions, cancer, and other diseases.
With extensive protein chemistry expertise, a consultative and multidisciplinary approach, and efficient turnaround times, Prolytix provides analytical services to support your mAb and pAb drug development. Whether you’re developing an intravenous immunoglobulin (IVIG) therapy for an autoimmune disorder or a mAb to treat a specific type of cancer, there’s only one place to go.
